ADMA Biologics Inc logo

ADMA Biologics Inc

ADMA
Healthcare|Biotechnology|USA
$9.11
-0.19 (-2.05%)
DCF (FCF)
$0.14
Tangible Book
$1.66
Graham Number
$4.99
Earnings Power
$0.22

About

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Stock Price

-50.7%(1Y)

Pipeline Summary

7 total trials
0
Phase 1
2
Phase 2
2
Phase 3
2
Phase 4
Completed: 4Unknown: 2Terminated: 1

BioScore

4.9/10
Cautious

Ownership

Recent Insider Trades

Grossman Jerrold BBUY
2026-05-276,400 shares @ $7.91
Grossman Jerrold BBUY
2026-05-1212,500 shares @ $8.01
Grossman Jerrold BBUY
2026-05-1112,500 shares @ $8.01
Grossman Adam SSELL
2026-03-1621,000 shares @ $15.16
Kestenberg-Messina Kaitlin M.SELL
2026-03-0910,096 shares @ $15.63

Recent News

2026-07-11 03:00:03
2026-07-09 22:00:07
2026-07-09 20:00:03
2026-07-09 15:00:05
2026-07-09 13:00:08
Data last updated: Jul 12, 2026, 07:39 PM